SYNTHESIS AND EVALUATION OF 4
1-METHYL CHALCONES FOR
THEIR ANALGESIC AND ANTIOXIDANT ACTIVITIES
*R. Padma, M. Lakshmi Surekha, Muggu. Muralikrishna and Ch. Ajay
A.M. Reddy Memorial College of Pharmacy, Dept. of Pharmaceutical Chemistry,
Uppalapadu, Andhra Pradesh 522601. India.
Literature review revealed that substituted chalcones and its derivatives
showed different pharmacological activities like antimicrobial,
anticancer, anti-inflammatory, antioxidant activity etc. In the present
study we planned to synthesize substituted 4-methyl chalcones
associated with antioxidant and analgesic activities.
OBJECTIVES
To synthesize the various new series of various substituted
4-methyl chalcones and to purify the final compounds by appropriate
recrystallization and or chromatographic techniques.
To characterize all the new compounds by analytical and spectral
analysis.
To evaluate analgesic activity of the compounds. Acetic acid induced writhing test in mice.
To screen the title compounds for in-vitro activities viz., nitric oxide scavenging activity,
reduction of DPPH stable free radical and inhibition of iron induced lipid peroxidation in
rat brain homogenate, hydroxyl radical scavenging activity, superoxide radical
scavenging activity, reducing power assay, ABTS+ radical scavenging activity.
General structure of chalcone
O
All the chalcones give pink coloration with concentrated H2SO4 (positive Wilson test) and
violet coloration with alcoholic ferric chloride solution.
Volume 8, Issue 13, 966-989. Research Article ISSN 2277– 7105
*Corresponding Author
R. Padma
A.M. Reddy Memorial
College of Pharmacy, Dept.
of Pharmaceutical
Chemistry, Uppalapadu,
Andhra Pradesh 522601.
India.
Article Received on 30 Sept. 2019,
Revised on 20 Oct. 2019, Accepted on 10 Nov. 2019
Chalcones on heating with traces of iodine in dimethyl sulfoxide (DMSO) for 2hrs give
the corresponding flavones.
Chalcones were converted to the corresponding flavonols by their oxidation using
hydrogen peroxide in methanolic sodium hydroxide solution and these flavonols showed
characteristic greenish yellow fluorescence in ethanolic solution as well as with
concentrated sulphuric acid.
General Methods Of Synthesis Of Chalcones
The chalcones are important intermediates in the synthesis of pyrazoles, isoxazoles and
pyrimidines. They can be obtained by the acid or base catalyzed aldol condensation of
2-hydroxy acetophenones with benzaldehydes (Claisen, L. et al., 1881).
Chalcones were prepared by using the following methods
1. Solvent free synthesis
2. Mortar and pestle synthesis
3. Synthesis of chalcones based on Suzuki reaction
4. Solvent free synthesis using silica- sulfuric acid as reagent.
Procedure for mortar and pestle synthesis
The solvent free synthesis of chalcones was carried out by grinding the substituted aromatic
aldehydes and the aetophenone in the presence of solid sodium hydroxide with a mortar and
pestle. In general, the chalcones were obtained in high yield and high purity. The by products
were easily removed by recrystallization. The result indicates a correlation between the
success of the solvent- free synthesis and melting point of the chalcone. (Rajendra K. et al.,
2006).
Procedure for solvent free synthesis using silica- sulfuric acid as reagent
Ketones (2 mmol), p- substituted benzaldehydes (4.2 mol) and silica-sulfuric acid (1.5 g
equal to 4mmol of H+) were mixed thoroughly, placed in a glass tube and capped. The
mixture was heated in an oven at 800C for 2-3.5h. After complete conversion of ketones
monitored by TLC, the mixture was cooled to room temperature. Dichloromethane (20-30
ml) was added and heated for 3-5 minutes. The reagent was removed by filtration. The filtrate
was concentrated and the solid residue was recrystallized from ethanol to afford the pure
products as pale yellow glittering solid. The catalyst was recycled by washing the solid
for 2h. and can be reusable for another reaction run. They are characterized by comparison of
their physical constants and spectral data reported in literature. (Thirunarayanan G. et al.,
2006).
They can be obtained b y the acid or base catalyzed aldol condensation of 2-hydroxy
acetophenones with benzaldehydes.
For example 1
2-hydroxy acetophenone and benzaldehyde react in the presence of 0.1M NaOH to give the
chalcone.
OH
COCH3
CHO
+
O Acetophenone Benzaldehyde
Chalcone NaOH
2. Some novel dihydro-α-ionone based chalcones have been synthesized.
O
+
CHO
R1
R2
R3
R4
KF/ Al2O3
Microwave
O
R1
R2
R3
R4
3. Reductive trimerization of aromatic aldehydes to 1,2,3 – triaryl – 2 – propen – 1 – ones as
well as rearrangements of aryl ketones to pinacolone analogues were efficiently achieved
R1
R1
O
R R
1
R1
O R
O
R1
R1
R1
TCS/Zn
R=Me,Ph
TCS/Zn
R=H
4. Substituted oxathiolone fused chalcones were prepared by condensation of 4-acetyl
-5-methoxy- 2 -oxo- benz (1,3) oxathiole with benzaldehydes under acidic conditions.
O S
O
O
OCH3 X
S O
O
OCH3
COCH3
+
CHO
X
ACOH H2SO4
ANTIOXIDANT ACTIVITY
Oxygen plays a vital role in diverse biological phenomena. It is essential for life, but it
can also provoke damaging effects. A free has been defined as any species capable of
independent existence that contains one or more unpaired electrons. Unpaired electron
makes the molecules unstable and highly reactive. Ironically these reactive species are
derived from normal physiological and metabolic processes that are essential to the cell.
The feature of the reaction of the free radicals with non radical is that they usually
Normally a balance between oxidative events and antioxidative force maintains the status
quo within living cells. A variety of enzymes help to maintain cells in reduced state
despite the presence of aerobic environment. Thus major cellular reducing agents, such as
ascorbate, glutathione and - tocopherol are present predominantly in their reduced form
(Slater, 1984; Yagi, 1987). In addition a number of enzymes scavenge and remove these
reactive chemical species. When normal balance is upset, either by loss of reducing
agents or protective enzymes or by increased production of oxidizing species or by both
events simultaneously, the tissue is considered to be under oxidative stress. An
antioxidant is any substance, when present at low concentrations compared to those of
oxidizable substrate significantly delays or prevents oxidation of that substrate. The term
oxidizable substrate includes almost everything found in living cells, including proteins,
lipids, carbohydrates and DNA.
TYPES OF FREE RADICALS
Free radicals can be defined as chemical species associate with an odd or unpaired
electron (Gupta. V.K. et.al., 1992; Halliwell B, et al., 1990). They are neutral, short lived,
unstable and highly reactive to pair up the odd electron and finally to achieve stable
configuration. Example of free radicals are super oxide (O-2, an oxygen centered radical),
thiyl (RS; a sulphur - centered radical), trichloromethyl (*CCl3, a carbon centered radical)
and nitric oxide (NO) in which the unpaired electron is delocalized between both the
atoms. (Halliwell and Gutteridge, 1990).
Oxygen -Derived Free Radicals (ODFR)
The free radicals and other reactive oxygen species are continuously produced in the
human body. The term reactive oxygen species is a collective one that includes not only
oxygen-centered radicals such as super oxide radical, singlet oxygen, and hydroxyl
radicals, but also some potentially dangerous non-radicals such as hydrogen peroxide, and
hypochlorous acid (Southern, P.A, et al., 1988).
There has been a great interest and focus on the role of free radicals, and the reactive
species usually derived from oxygen products in the inflammatory process. Formation of
these highly reactive oxygen species (ROS) is integral to the phagocytic action of
polymorphonuclear leukocytes (PMNs). Stimulation of the cell by chemo attractants such
as LTB4, or products of the complement cascade, results in activation of the
These include super oxide radical and hydrogen peroxide, and possibly the very reactive
hydroxyl radical (Flohe L, et al., 1985).
ODFR reactions mediated by activated neutrophils are likely to have a role in vascular
damage, endotoxin shock and burn induced damage. ODFR induced damage in
inflammatory disorder may be mediated through increased neutrophil elastase activity as
well.
Toxic effects of oxygen derived free radicals (ODFR) include, protein oxidation, lipid
peroxidation (which leads to change in membrane fluidity, membrane permeability and
ultimately cell necrosis), carbohydrate oxidation and nucleicacidoxidation (Halliwell.B.
et.al., 1990).
CHEMISTRY
Materials
Melting points were determined in open capillaries on a Tempo melting point apparatus, and
were uncorrected. UV spectra, were recorded on SYSTRONICS UV/VIS
SPECTROPHOTOMETER, FTIR spectra were obtained using PERKIN-ELMER, Mass
spectra using BXI SYSTEM. Proton NMR spectra were taken is using AVANCE-300 MHz.
Aldehydes were procured from Sigma Aldrich and S.d fine chemicals. All other chemicals
are of AR grades. Purity of the compounds was checked by Thin layer chromatography
(TLC) using precoated plates with Silica gel G, and spots were detected by iodine chamber
and UV chamber.
Methods
General procedure for the synthesis of (E)-3-(41-Methyl phenyl)-1-(substituted phenyl) prop-2-ene-1ones(compounds, 1-12)
Synthesis of (E)-3-(41-methyl phenyl)-1-(phenyl) prop-2-ene-1-one
Equimolar concentrations of 4-methyl acetophenone (412mg, 0.025mol) and unsubstituted
benzaldehydes (350mg, 0.025 mol) were dissolved in 20ml of methanol. Methanolic Sodium
hydroxide solution (0.03 mol) was added slowly and the mixture was stirred for two hours or
till the completion of the reaction(progress of the reaction checked by TLC). The mixture was
acidified with 0.1 N HCl. Then it was filtered, washed with water, dried and recrystallised
SCHEME
CHO
+
O H3C
O H3C
R Room temperature NaOH
PHYSICOCHEMICAL DATA OF COMPOUNDS (1-12)
Compound 1 : (R=H)
Chemical name : (E)-3-phenyl-1-p- tolyl prop-2-en-1-one
Molecular formula : C17H14O2
TLC : Rf (3:1 benzene: ethyl acetate):0.70
UV (methanol) : 249 nm
Compound 2 : (R=4-Cl)
Chemical name : (E)-3-(4-Chlorophenyl)-1-p- tolyl prop-2-en-1-one
Molecular formula : C16H13OCl
TLC : Rf (3:1 benzene: ethylacetate): 0.86
UV (methanol) : 283 nm
1
H NMR (CDCl3) : δ 2.4 – 2.5 (d, 3H, CH3), δ 7.27-7.31(d, Hα)J=17.5,
FTIR (KBr)cm-1 : 3056. 7(Ar-H); 1670.9(C = O), 1561.1 (C = C)
Compound 3 : (R=4-CH3)
Chemical name : (E)-3-(4-methylphenyl)-1-p – tolyl prop-2-en-1-one
Molecular formula : C17H16O
TLC : Rf (3:1 benzene: ethyl acetate): 0.91
UV (methanol) : 252 nm
1
H NMR (CDCl3) : δ 2.36(s, 3H, CH3), δ 2.43(s, 3H, CH3)
: δ 7.18-7.22(d, Hα) J=17.2, δ 7.35- 7.85(d, Hβ), J=17.2.
: δ 7.0-7.50(d, 10H, Ar-H)
FTIR (KBr) cm-1 : 3061.0 (Ar-H); 1660.3(C = O), 1593.2 (C = C)
Compound 4 : (R= 4- N(CH3)2
Chemical name : (E)-3-(4-dimethylaminophenyl)-1-p-tolylprop-2-en-1-one
Molecular formula : C18H19ON
TLC : Rf (3:1 benzene: ethylacetate) : 0.71
UV (methanol) : 305 nm
1
H NMR (CDCl3) : δ 2.30 –2.45 (d, 3H, CH3), δ 2.95-3.05(d, 6H,(CH3)2)
: δ 6.88- 6.94 (d, Hα) J=17, δ 7.427.46(d,Hβ), J=17
: 6.56-7.50(m,10H,Ar-H)
FTIR (KBr) cm-1 : 3036.2 (Ar-H); 1655.9(C = O), 1592.6 (C = C)
Compound 5 : (R = 4- OCH3)
Chemical name : (E)-3-(4-methoxyphenyl)-1-p-tolyl prop-2-en-1-one
Molecular formula : C17H16O2
TLC : Rf (3:1 benzene: ethyl acetate) : 0.81
UV (methanol) : 259 nm
1
H NMR (CDCl3) : δ 2.34 – 2.35(d, 3H, CH3), δ 3.80-3.90( d, 3H, OCH3)
: δ 6.89-6.94(d, Hα) J=17.3, δ 7.51-7.54(d, Hβ),J=17.3.
: δ 6.85-7.6(d, 10H, Ar-H)
FTIR (KBr)cm-1 : 3041.6 (Ar-H); 1639.7(C = O), 1597.6 (C = C)
Compound 6 : (R=3,4,(OCH3)2)
Chemical name : (E)-3-(3,4-dimethoxyphenyl)-1-p-tolyl prop-2- en-1-one
TLC : Rf (3:1 benzene: ethylacetate) : 0.56
UV (methanol) : 313 nm
1
H NMR (CDCl3) : δ 2.35-2.50 (d, 3H, CH3), δ 3.85-3.95(d, 6H, (OCH3)2)
: δ 6.85-6.91(d, Hα) J=17.2, δ 7.45-7.49(d, Hβ), J=17.2
: δ 6.85- 7.5(m, 9H, Ar-H)
FTIR (KBr)cm-1 : 3047.4 (Ar-H); 1632.1(C = O), 1597.5(C = C)
Compound 7 : (R=3,4,5,(OCH3)3)
Chemical name : (E)-3-(3,4,5-trimethoxyphenyl)-1-p-tolyl prop- 2-en-1-one
Molecular formula : C19H20O4
TLC : Rf (3:1 benzene: ethylacetate) : 0.85
UV (methanol) : 285 nm
1
H NMR (CDCl3) : δ 2.36 (s, 3H, CH3), δ 3.30-3.85(d, 9H,(OCH3)3)
: 7.32- 7.35(d, Hα) J=17, 7.56-7.60(d, Hβ), J=17.
7.1-7.7(m,4H,Ar-H)
FTIR (KBr) : 2957 (Ar-H); 1612.9(C = O), 1568.1 (C = C)
MASS(m/z) : 313.24(M++1)
Compound 8 : (R=2-OH)
Chemical name : (E)-3-(2-hydroxyphenyl)-1-p-tolyl prop-2-en-1-one
Molecular formula : C16H14O2
TLC : Rf (3:1 benzene: ethylacetate) : 0.33
UV (methanol) : 342 nm
Compound 9 : (R=4-OH, 3-OCH3)
Chemical name : (E)-3-(4-hydroxy,3-methoxyphenyl)
-1-p-tolyl prop-2-en-1-one
Molecular formula : C17H16O3
TLC : Rf (3:1 benzene: ethyl acetate) : 0.32
UV (methanol) : 349 nm
Compound 10 : (R=4-OH, 3,5 (OCH3)2)
Chemical name : (E)-3-(4-hydroxy,3,5-dimethoxyphenyl)-1-p- tolyl prop-2-en-1-one
Molecular formula : C18H18O4
UV (methanol) : 325 nm
Compound 11 : (R=4-OH, 3-OCH3, 5-Br)
Chemical name : (E)-3-(5-bromo,4-hydroxy-3-methoxy phenyl)-1- p-tolyl prop-2-en-1-
one
Molecular formula : C17H16O3Br
TLC : Rf (3:1 benzene: ethylacetate) : 0.48
UV (methanol) : 286 nm.
1
H NMR (CDCl3) : δ 2.25-2.40(d, 3H, CH3), δ 3.629-3.639(d, 3H, CH3)
: 6.82-6.89(d, Hα) 17.6, 7.06-7.1(d, Hβ), J=17.6, 6.45-7.45(m, 6H, Ar-
H)
FTIR (KBr) : 3062.7 (Ar-H); 1656.5(C = O), 1583 (C = C)
MASS(m/z) : 346.04(M++1)
Compound 12 : (R= 4-OH, 3-OCH3 5-I)
Chemical name : (E)-3-(5-iodo,4-hydroxy,3-methoxyphenyl)-1-p-tolyl
prop-2-en-1-one
Molecular formula : C17H16O3I
TLC : Rf (3:1 benzene: ethyl acetate) : 0.62
UV (methanol) : 319 nm
PHARMACOLOGICAL STUDIES
Analgesic activity
Acetic acid induced writhing test
Mice of either sex approximately 20-25gm are used. An aliquot of 0.25 ml of 0.6% acetic
acid was injected intraperitoneally in each animal. The animal reacts with a characteristic
stretching behavior, i.e. a series of constrictions occur that travel along the abdominal wall,
some times accompanied by turning movements of the body and extension of the hind limbs.
This response is called Writhing.
The mice were divided into 17 groups. Each group contains four animals. One group
consisting of four served as control, while the other groups of four animals received the test
compounds or standard drug. The mice were dosed (100mg/kg) orally with test compounds
one hour before injection of 0.25 ml of 0.6% acetic acid was injected intraperitoneally in each
IN VITRO ANTIOXIDANT STUDIES
Materials
Sodium nitroprusside, N-napthylethylenediamine dihydrochloride, were obtained from S.d
fine chem., Ltd. 1-1-dipheny1-2-picrylhydrazy1 (DPPH), was obtained from Sigma
Chemicals. All other chemicals were of laboratory grade.
Instruments
Absorbance was measured in SYNSTRONIC UV-VIS-SPECTROPHOTOMETER – 117.
Centrifugation was done using REMI centrifuge meachine.
METHODS
Interaction with stable free radical DPPH (Blios et al., 1958)
Solutions of various test compounds at 100 M concentration were added to 100 M DPPH
in 95% ethanol and the tubes were kept at an ambient temperature for 20 minutes and the
absorbance was measured at 517 nm.
Assay of Nitric Oxide (NO) Scavenging activity (Marcocci, 1994)
Sodium nitroprusside (10M) in phosphate buffer pH 7.4 was incubated with 100 M
concentrations of test compounds dissolved in a suitable solvent (dioxan/methanol) and tubes
were incubated at 25oC for 120 minutes. Control experiment was kept without test compound
but equal amount of solvent, was added in an identical manner. 2 ml of incubation solution
was removed and diluted with 2 ml of Griess reagent. The absorbance of the chromphore
formed during diazotization of nitrite with sulphanilamide and subsequent coupling with
N-napthylethylene diamine was read at 546 nm (Halliwell B. et al., 1987).
Composition of Griess reagent (Sorba et al., 1997)
Sulphanilamide : 1%
N-Napthylethylene diamine : 0.1%
10% orthophosphoric acid : 2%
Distilled water : 100 ml
Inhibition of iron induced Lipid peroxidation
Preparation of rat brain homogenate
Albino wistar rats (180-250g) of either sex were used for the study. Decapitated and removed
brain tissue with blood. Tissue was weighed and homogenate (10% w/v) was prepared in 0.15
M KCl and centrifuged at 800 g for 10 minutes (Sharma, 1976). The supernatant was used
immediately for the study. (Shivakumar et al., 1992).
Procedure
The incubation mixture contained in a final volume of 1 ml, brain homogenate (400 μl), KCl (150 mM) and ethanol (10 μl) or test compound dissolved in ethanol.
Lipidperoxidation was initiated by adding, fe3+ (100μM) to give the final concentration stated
(Ciutti M, et al., 1991). After incubating for 20 minutes at 370C, reactions were stopped by
adding 2 ml of ice-cold 0.25 M HCl containing 15% trichloroaceticacid, 0.38%
thiobarbituricacid and 0.05% BHT. Following heating at 80oc for 15 minutes samples were
cooled and centrifuged at 800g for 10 minutes. The absorbance of the supernatant was
measured at 532 nm. Percentage inhibition of TBARS (thio barbituric acid reactive
substances) formed by test compounds was calculated by comparing with vehicle only
experiments (Braughler et al., 1993). Iron solutions were prepared fresh in distilled water and
used immediately. Since most buffers trap hydroxyl radical or interfere with iron conversion
(Duncan et al., 1986), the reactions were carried out in unbuffered 0.15M KCl.
Hydroxyl radical scavenging activity
The scavenging capacity for hydroxyl radical was measured according to the modified
method. The assay was performed by adding 0.1 ml EDTA, 0.01 ml Fecl3, 0.1ml H2O2,
0.36ml Deoxyribose, 1.0ml of test compounds dissolved in methanol (25-125μg/ml), 0.33ml
of phosphate buffer (PH 7.4) and 0.1 ml of ascorbic acid in sequence. The mixture was then
incubated at 370 C for 1 hour. A 1.0 ml of portion of the incubated mixture was mixed with 1
ml of 10% TCA and 1 ml of 0.5%TBA to develop the pink chromogen, which was measured
at 532nm. (Mecrod J.M. et al., 1969).
Reducing power
The reducing power of test compounds was determined by Oyaizu method. Different
concentration of test compounds (25,50, 75,100,125 µM) was mixed with phosphate
buffer(2.5ml, 0.2M, PH 6.6). The mixture was incubated at 500C for 20 min. 2.5ml of 10%
TCA was added to the mixture, which was then centrifuged at 3000 rpm for 10 min. The
solution (0.1%) was added and absorbance was measured at 700 nm. The absorbance of
reaction mixture indicates reducing power (Oyaizu M. et al., 1986).
Superoxide scavenging activity
Superoxide scavenging activity of the compounds was determined by Mcord and Fridorich
method, which depends on the light induced superoxide generation by riboflavin and the
corresponding reduction of nitro blue tetrazolium (NBT). The concentrations assay mixture
contained different test compounds, ethylene diamine tetra acetic acid (6µM), NBT (50µM),
riboflavin (2µM), & phosphate buffer (7.8 PH) to give a total volume of 3ml. The tubes were
uniformly illuminated with an incandescent light (40 volts) for 15 min & measured the
optical density at 560nm. (Elizabeth K. et al., 1996)
ABTS+ radical cation scavenging activity
The ABTS+ radical cation scavenging activity of test compounds, ascorbic acid (as standard)
was determined as mentioned. Briefly, 5.0 ml of 140nm potassium per sulfate over night in
the dark place to yield the ABTS+ radical cation. Prior to use in the assay, the ABTS+ radical
cation diluted with 50% ethanol for an initial absorbance of 0.700 (1:88 ratio) at 734nm. Free
radical scavenging activity was assessed by mixing 1.0 ml diluted ABTS+ radical cation with
10µl of test antioxidant & monitoring the change in absorbance at 0, 0.5, 1min & again at
5min intervals until a steady state was achieved. The antioxidant capacity of tested
compounds was expressed as IC50, the concentration necessary for 50% reduction of ABTS+.
(Re R., et al., 1999).
RESULTS AND DISCUSSION
Chemistry
Due to the great importance of α,β- unsaturated carbonyl moiety in broad range of natural and
synthetically designed products, the development of novel synthetic methods remain
interesting in research area to synthesize chalcones and their derivatives. A vila et al.,
reported that chalcones synthesized by condensation of acetophenone and ring substituted
aldehydes under alkaline conditions, is attractive since it specially generates (E)-isomer,
normally in high yield. These Chalcones are also reported to be a geometrically pure and with
trans configuration (J Hα-Hβ=15.5-16.0) as observed from 1H NMR spectra. (A Vila et al.,
In the present study, ring substituted chalcones were synthesized by Claisen - Schmidt
condensation using 4-methyl acetophenone and substituted aromatic aldehydes.
The chalcones were synthesized by a base catalyzed claisen- Schmidt reaction between a
substituted benzaldehyde and a substituted acetophenone. Mechanistically, the reaction
involves formation of a carbanion from the acetophenone in the presence of the base NaOH,
followed by nucleophillic attack by the carbanion on the carbonyl carbon of the benzaldehyde
and subsequent loss of water to give the chalcone. Substituted chalcones (1-12) were
prepared by reacting 4-methyl acetophenone with the corresponding substituted aromatic
aldehydes in the presence of methanolic sodium hydroxide at room temperature. Some
substitutions such as 4-methoxy(5), 3,4,5 – trimethoxy[7] and Unsubstituted derivative(1)
took longer reaction time (10-12 hr). Majority of the compounds were obtained in less than
two hours. All the compounds were purified by recrystallization from methanol and ethyl
acetate as solvents.
Other methods for the synthesis of chalcones, are
1. Solvent free synthesis
2. Mortar and pistle synthesis
3. Synthesis of chalcones based on Suzuki reaction.
4. Solvent free synthesis using silica-sulfuric acid as reagent.
Twelve compounds (1-12) were synthesized with the yields generally ranging from 50-72%,
4- methyl, and 4- dimethylamino derivatives were obtained at highest yields (53-72%).
The physical data such as melting points and yields are given in the table 1.
The chalcone derivatives of the present study were characterized by UV,IR, 1H NMR, and
mass spectral analysis. The UV absorption peaks were observed in the region of 250 – 340
nm. The IR spectra of compounds (2,3,4,5,6,7 and 11) displayed bands at 3062.7 – 3022.1
cm-1 due to C-H (Ar-H) stretching, 1670.9 – 1612.9 cm-1 due to C=O stretching, 1602.6 –
1568.1 cm-1 due to C=C stretching.
1
HNMR spectra were taken for compounds (2,3,4,5,6,7, and 11) which also supported the
structures assigned. These compounds displayed a doublet at δ 7.37- 7.12 (d, Hβ) a doublet at
δ 7.05-6.82 (d, Hα) due to hydrogens of the α,β- unsaturated carbonyl group and multiplets in
2.36- 2.43due to methyl substitution on the ring. Compound 4 displayed doublet at 2.95-3.05
due to dimethyl amino substitution. Compound 5 displayed doublet at 3.80-3.90due to
methoxy substitution. The structure of the compounds was also assigned by mass spectral
analysis which showed(M++1) peaks of the compounds. The mass spectra of the compound 7
showed a characteristic molecular ion peaks (M++1) at 313.24 and the compound 11 showed
a characteristic molecular ion peaks (M++1) at 347.05.
PHARMACOLOGICAL STUDIES
Analgesic activity (Acetic acid induced writhing test)
Naturally occurring and synthetic chalcones have shown promising biological activiy and
safety profile and have shown potential for use as lead compounds for the discovery of
analgesic and anti-oxidant agents(Ni, L et al., 2004). A number of chalcones and their
derivatives have also been found to inhibit the synthesis of nitric oxide (NO) and
prostaglandins (PG), which are products of nitric oxide synthase (NOS) and cyclooxygenase
(COX) pathways, respectively (Ahmad, S et al., 2006).
Correa. R et al reported that some synthetic chalcones, or those derivatives derived from the
abundant natural product 2-hydroxy-4,6-dimethoxy acetophenone, exhibit pronounced
antinociceptive effect in the mice writhing test( correa, R et al., 2001).
Anti-nociceptive activity was expressed as the reduction in number of abdominal
constrictions between the control animals and the mice treated with the test compounds.
Compous-buzzi et all reported the, synthesis of a series of Acetamidochalcones and evaluated
for anti-nociceptive activity using mice writhing test. All compounds showed good activity
when compared to standard drugs, acetylsalicylic acid and acetaminophen.
Lucky O. et al reported the synthesis of chalcones and evaluated for anti-inflammatory
activity. All compounds showed good to moderate activity when compared to standard drugs.
The electron withdrawing groups, 4-chloro substitution displayed relatively low
anti-inflammatory activity. Present studies, the 4-chloro derivative showed good analgesic
activity.
The unsubstituted aromatic ring containing chalcones were proved have less analgesic
activity. The substitution of aromatic ring at 4th position by methyl group exhibited potent
induced writhing in mice, at 100mg/kg body weight and data is given in table 2.The
4-dimethyl amino (4), and 3,4,5-trimethoxy(7) derivatives showed highest inhibition (73-71%)
on acetic acid induced writhings in mice. The unsubstituted derivative showed 52%
inhibition.4-methyl derivative (3) showed the potent activity (70%) when compared to
standard drug aspirin (69%) thus indicating the importance of electron releasing substituent’s.
The electron withdrawing groups such as 4-chloro derivative (2) showed good activity (69%).
and 5-bromo vanillinyl derivative (11) also showed good activity (69%). The other phenolic
derivatives like 2-hydroxy (8), 4-hydroxy-3-methoxy (9), 4-hydroxy-3,5-dimethoxy
derivatives (10) showed good activity (54-64%). The other derivatives showed moderate
activity.
IN VITRO ANDIOXIDANT STUDIES
Reduction of DPPH by test compounds
Interest in the involvement of reactive oxygen species (ROS) in various disorders has been
increasing. In particular, they were thought to play an important role in the development of
inflammatory disorders. A radical scavenging antioxidant reacts rapidly with
1,1-diphenyl-2-picrylhydrazyl stable free radical(DPPH). Hence the ability of the test compounds to
scavenge the stable radical has been determined (Halliwell et al., 1990).
Antioxidant reacts with DPPH and convert it to 1,1- diphenyl-2-picrylhydrazine. The change
in the absorbance produced in the reaction measures the antioxidant properties.
Reactive oxygen species are thought to play an important role in the development of
inflammatory diseases (Rajkumar et al., 1995). The nitrogen centered stable free radical 1,1-
diphenyl-2-picrylhydrazyl(DPPH) has often been used to characterized phenolic antioxidants.
It is reversibly reduced, and due to its unpaired electrons, densely coloured. This property
makes it suitable for spectrophotometric studies. A scavenging antioxidant reacts with DPPH
stable free radical and convert it to 1,1- diphenyl-2-picrylhydrazine. The change in
absorbance produced in this reaction has been used to measure antioxidant properties.
The odd electron in the DPPH free radical showed a strong absorption maximum at 517 nm
and purple in colour. when the odd electron of DPPH radical becomes paired with a hydrogen
from a free radical scavenging antioxidant to from the reduced DPPH. The decolourisation is
The compounds were (1-12) screened for reduction of DPPH at 25, 50, 75,100 and 125µM
concentration. The data is given in table 3. At 125 µM concentration some of the compounds
like 3,4,5- trimethoxy, 2- OH, 4- dimethyl amino, and 4- OH, 3- OCH3 showed highest
activity(84 - 92%) 4-methoxy(5), 4-OH-3,5-dimethoxy showed moderate activity (64-65%).
It is interesting to note that, the 3,4,5- trimethoxy(7), 4-hydroxy – 3- methoxy vanillinyl(9)
and 4-dimethylamino derivatives showed significant activities at lower concentrations and
showed IC50 values of 60µM, 60 µM, and 75 µM respectively as compared to standard.
Scavenging of Nitric oxide free radical
Nitric oxide (NO) is an important modulator of physiological and pathological function in the
cardiovascular, neuronal and immune systems and it is involved as an intracellular signal and
defensive cytotoxin in the nervous, muscular, cardiovascular and immune systems.
Sodium nitroprusside in aqueous solution at physiological pH spontaneously generates nitric
oxide (Marcocci et al., 1994). This nitric oxide reacts with oxygen to produce nitrite ions
which can be estimated using griess reagent (Gutteridge et al., 1987). Scavengers of nitric
oxide (NO), compete with oxygen leading to reduced production of nitric oxide.
All the compounds were tested for their ability to scavenge nitric oxide at 25, 50, 75, 100,
125 µM concentrations. The data is given in table 5.
Many compounds, such as 5- iodo vanillinyl and bromo vanillinyl, 4- dimethylamino(4),
derivaties showed (82 - 86%) potent inhibitory activity on nitric oxide scavenging at 125 μM
Among the tested compounds 4-methyl(3), 2-hydroxy(8), 3,4-dimethoxy(6), 4-
hydroxy-3,5-dimethoxy (10) derivatives (78-71%) showed good activity and the other compounds the un
substituted (1), 3,4,5 – trimethoxy (7), 4-Hydroxy-3-methoxy(9), 4-chloro(2), showed
moderate activity.(43-65%). It is interesting to note that substitution by phenolic hydroxyl
groups and other electron releasing substituents on the 41-methyl chalcones resulted in
pronounced inhibition of nitric oxide. When both he rings of chalcone are substituted by 4-
methyl groups, the compound exhibited lowest IC50 value.
IC50 values of the title compounds were calculated and 4-dimethylamino(4), and 5-bromo
vanillinyl and 5-iodo vanillinyl (11,12) derivatives were found to be more active with 65 µM,
77 µM, and 85 µM respectively. 4-methyl(3), and 4-methoxy(5) derivatives showed IC50
values of 85 µM and 95 µM.
Effect of compounds (1-12) on iron induced lipid peroxidation in rat brain homogenate
Ferric stimulates lipid peroxidation through various mechanisms, as the generation of
hydroxyl radical (Richmond et al., 1979), decomposition of lipid peroxides (Chase et al.,
1987), forming perferryl (or) ferryl species (Koppel et al., 1984) and free radical reaction
mechanisms. The role of lipid peroxidation in various diseases such as cancer, inflammatory
diseases etc was clearly established (Rajkumar et al., 1993). Compounds that inhibit lipid
peroxidation by interfering with the chain reaction of peroxidation and by scavenging
reactive free radical mediated tissue damage could be of great therapeutic importance.
All compounds were tested for their inhibitory effect on ferric induce lipid peroxidation at 25
µM, 50 µM, 75 µM, 100 µM, 125 µM concentration and data is given in table 6.
Compounds like 4- methoxy (5), and 4- dimethyl amino (4) showed IC50 values at 90 µM,
and 110 µM, respectively. Some of the compounds 4-hydroxy-3,5- dimethoxy (10) derivative
showed similar activity (110 µM) as compared to standard.
Scavenging of hydroxyl radical
Hydroxyl radical were generated by using the ferric ions (Fe3+)/ ascorbic acid reaction
system. The detection of hydroxyl radicals was carried out by measuring the amount of
formaldehyde generated from the oxidation of dimethyl sulfoxide. the reaction mixture
contained 0.1 mM EDTA, 167 µM Fe3+, 0,33mM DMSO in phosphate buffer of 50mM
added finally to initiate the reaction. Trichloro acetic acid (17%, w/v) was added to terminate
the reaction. The contents were observed spectrophotomatically at 412nm for the detection of
formaldehyde. Ascorbic acid was used as reference compound for comparative study.
The compounds were tested for their ability of hydroxyl radical scavenging activity at
25,50,75,100 and 125µM concentration. Data is given in table 7.
The phenolic derivative, 4-hydroxy- 3,5-dimethoxy analog (10) showed highest
activity(91%), at 125μM concentration among all substituted derivatives. 4-methoxy(5), 4-
dimethylamino(4) and 4-hydroxy-3-methoxy(9) showed good activity(78-72%).
3,4-dimethoxy and 3,4,5-trimethoxy(6,7) also showed good activity.(69-69%) which suggest that
the importance of substitution methoxy group.
The substitution with electron donating groups such as 4-methyl (3), and showed good
activity (65%).
The substitution by electron withdrawing groups such as 4-chloro(2) derivatives exhibited
moderate activity (59%). 5-bromo vanillinyl and 5-iodo vanillinyl derivatives also showed
moderate activity.
It is interesting to note that, among these compounds, the 4-Hydroxy-3,5-dimethoxy(10),
vanillinyl (3), 4-dimethylamino (4), 4-methoxy (5) derivatives showed significant activities at
lower concentrations and showed IC50 values of 60µM, 80µM, 95µM and 100µM
respectively.
Assay for Reducing power
Hydroxyl radicals were generated by using the ferric ions (Fe3+)/ ascorbic acid reaction
system. The detection of hydroxyl radicals was carried out by measuring the amount of
formaldehyde generated from the oxidation of dimethyl sulfoxide. the reaction mixture
contained 0.1 mM EDTA, 167 µM Fe3+, 0,33mM DMSO in phosphate buffer of 50mM
(pH7.4) and 0.1ml test compounds (1mM) solution. Ascorbic acid (150µl. 10mm in phosphate
buffer) was added finally to initiate the reaction. Trichloro acetic acid (17%, w/v) was added
to terminate the reaction. The contents were observed spectrophotomatically at 412nm for the
detection of formaldehyde. Ascorbic acid was used as reference compound for comparative
All the compounds were tested for their ability of Reducing power activity at 25.50,75,100,
and125µM concentration. Data is given in table 8.
Among these compounds 5-bromo vannillinyl analog (11) showed highest activity(85%). The
phenolic compounds like 2-hydroxy(8), and 5-iodo vanillinyl (12) derivatives showed good
activity.(73%-72%). and 4-hydroxy-3,5-dimethoxy(10) derivatives showed significant
activity (70%).
The 4-dimethylamino(4), and 4-methyl(3), derivatives showed significant activity
(70%,70%), other substituted derivatives, such as 4-methoxy (5), 3,4-dimethoxy(6), 3,4,5-
trimethoxy(7) also showed good inhibitory activities ( 62%, 65%,56%) and the unsubstituted
derivative(1) showed moderate activity(48%) at 125µM concentration.
IC50 values of the title compounds were determined and 5-bromo vanillinyl(11), 4-OH,
3,5-dimethoxy (10), 4-methyl (3) and 4- dimethylamino(4) derivatives showed IC50 values of 75
µM, 80 µM, 85µM and 90 µM respectively, while the standard drug, Ascorbic acid exhibited
Scavenging of Superoxide radical
Super oxide scavenging activity of the test compounds was determined by Mcord &
Fridovich method, which depends on light induced superoxide generation by riboflavin and
the corresponding nitro blue tetrazolium (NBT). It was hypothesized that drugs might
scavenge free radicals by donating the allylic hydrogen of the unsaturated lactone ring. It was
found that the stoichiometry of the reaction between test compounds and superoxide radical
generated from KO2 in DMSO was 2 to 1.
The compounds were tested for their ability of superoxide radical scavenging activity at 25,
50,75, 100 and 125µM concentration. Data is given in table 9.
The 4-hydroxy-3,5-dimethoxy derivative(10) showed appreciable activity(82%). The
substitution by electron with drawing group such as 4-chloro(2) exhibited good activity.
(63%).
The phenolic compound, 2-hydroxy (8), showed significant activity (62%) at 125μM. The
activity of this derivative might be due to the presence of phenolic group which has ability to
The substitution by an electron donating groups such as 4-methyl(3), 4-methoxy(5) and 4-
dimethyl amino derivatives showed moderate activities (45%, 54%, and 59%).
The 5-bromo(14) and 5-iodo(15) vanillinyl derivatives showed moderate activity(53% and
48%). 4- hydroxy-3,5-dimethoxy(10), 2-hydroxy(8), 3,4,5-trimethoxy(7) and 4- dimethyl
amino (4) showed IC50 values of 80µM, 85µM, 85µM, and 105 µM respectively. Where as
the standard, α- tocopherol showed IC50 value of 95 µM.
CONCLUSION
Twelve analogs of 4-methyl chalcones were synthesized and characterized by IR, 1HNMR,
and Mass spectral analysis. Substituted aromatic aldehydes were condensed with 4-methyl
acetophenone to yield the title products. All the synthesized compounds were evaluated for
their analgesic activity by using acetic-acid induced writhing method. Among the compounds
evaluated 4-dimethyl amino (73%), 3,4,trimethoxy benzaldehyde (71%) and
5-bromovanillinyl derivatives (69%) showed highest activity. All the compounds were tested
for the antioxidant activities like reduction of DPPH stable free radical, nitric oxide
scavenging activity, inhibition of lipid peroxidation, hydroxyl radical, superoxide ABTS+
scavenging activity and reducing power method. 4-dimethyl amino, 2-hydroxy, 4-hydroxy-3,
5- dimethoxy, 5-bromovanillinyl and 5-iodo vanillinyl derivatives showed good antioxidant
activity in all in vitro models.
REFERENCES
1. Ampai Phrutivorapongkul.; Vimolmas Lipipun.; Nijsiri Ruangrungsi.; Kanyawim
Kirtikara.; Kiyohiro Nishikawa.; Sakiko Maruyama.; Toshiko Watanabe.; and Tsutomu
Ishikawa. Studies on the Chemical Constituents of Stem Bark of Millettia leucantha:
Isolation of New chalcones With Cytotoxic, herpes Simplex Virus and
Anti-inflammatory Activities. Chem. Pharm. Bull, 2003; 51(2): 187-190.
2. Aneta Modzelewska.; Catherine Pettit.; Geetha Achanta.; Nancy E. Davidson.; Peng
Huang Saeed R. Khan. Anticancer activities of novel chalcone and bis-chalcone
derivaties. Bioorganic & Medicinal Chemistry, 2006; 14: 3491-3495.
3. Aracio A.; M.C. Terencio.; M.J. Alcaraz.; J.N. Dominguez, C. Leon.; M.L. Ferrandiz.
Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual
cyclo-oxygenase -2/5-lipcyclo-oxygenase inhibitor. Lifesciences, 2007; 80: 2108-2117.
4. Bai-Luh Wei.; Chi-Huang Teng.; Jih-Pyang Wang,; Shen-Jeu won.; Chun-Nan Lin.
and inhibitors of nitric oxide production in rat macrophages. European Journal Medicinal
Chemistry, 2007; 42: 660-668.
5. Baviskar B.A.; Bhagyesh Baviskar.; M R Shiradkar.; U A Deokate.; S S Khadabadi.
Synthesis and Antimicrobial Activity of Some Novel Benziimidazolyl chalcones,
European Journal of Chemistry, 2009; 6(1): 196-200.
6. Claisen, L.; and Claparede, A.; Ber., 1881; 14: 2463.
7. Datta, S.C.; Murthi, V.V.S.; and Seshadri, T.R., Indian J.Chem., 1971; 9:614.
8. Dhanaji H Jadhav.; C S Ramaa.; Synthesis and anti- inflammatory activity, 46B:
2064- 2067.
9. Halise Inci Gul.; Kadir Ozden Yerdelen.; Umashankar Das.; Mustafa Gul UL.; Bulbul
PanditT.; Pui- Kai Li.; Jonathan Richard Dimmock. Synthesis and Cytotoxicity of Novel
3- Aryl – 1- (31- dibenzylaminomethyl -41- hydroxyl phenyl) – Propenones and Related
Compounds, Chem Pharm.Bull., 2008; 56(12): 1675-1681.
10.Hsin- Kaw Hsieh.; Tai- Hua Lee.; Jih-Pyang Wang.; Jeh-Jeng wang and Chun-Nan Lin.
Synthesis of Anti-inflammatory Effect of Chalcones and Related Compounds,
Pharmaceutical Research, 1998; 15: 1.
11.Hua- Lin Liao.; Ming–Kuan Hu. Synthesis and Anticancer Activities of 5,6,7-
Trimethylbaicalein Derivatives, Chem Pharm Bull., 2004; 52(10): 1162-1165.
12.Julia Cianci.; Jonathan B. Baell.; Bernard L. Flynn.; Robert.; W. Gable.; Jorgen A.
Mould.; Dharm Paul and Andrew J.Harvey. Synthesis and biological evaluation of
chalcones as inhibitors of the voltage-gated potassium channel Kv1.3, Bioorganic &
Medicinal chemistry Letters, 2008; 18: 2055-2061.
13.Li-Ming Zhao.; Hai-Shan Jin.; Liang–Peng Sun.; Hu–Ri Piao and Zhe –Shan Quan.
Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivaties,
Bioorganic & Medicinal chemistry Letters, 2005; 15: 5027-5029.
14.Maayan.; Shmuel.; Ohad, nerya and Soliman k.; Bioorganic and Medicinal chemistry,
2005; 13(2): 433.
15.Marek T. Konieczny.; Wojciech Konieczny.; Michal Sabisz.; Andrzej Skladanowski
Roland Wakiec.; Ewa Augustynowicz- Kopec.; Zofia Zwolska. Acid catalyzed synthesis
of oxathiolone fused chalcones. Comparision of their activity toward various
microorganisms and human cancer cell line. European Journal Medicinal Chemistry,
16.MISS Rashmi Jain.; O.P. Chourasia.; Tirumala Rao. Synthetic and Antimicrobial studies
of Some New Chalcones of 3 – Bromo – 4 – (p- tolyl sulphonamido) acetophenone.
European Journal of Chemistry, 2004; 1(3): 178–183.
17.Nesrin gokhan-kelecki.; Samiye yabanoglu.; Esra kupeli.; Umut salgm.; Ozen ozgen.;
Gulberk ucar.; Erdem yesilada.; Engin kendi.; Akgul yesilada.; and A. Altan bilgin. A
new therapeutic approach in Alzheimer disease: Some novel pyrazole derivatives as dual
MAO-B inhibitors and anti-inflammatory analgesics. Bioorganic and Medicinal
chemistry, 2007; 15: 5775-5786.
18.Ohad Nerya.; Ramadan Musa.; Soliman Khatib.; Snait Tamir.; Jacob Vaya, Chalcones as
potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers.
Phytochemistry, 2004; 65: 1389-1395.
19.Poonam Shukla.; Amar Bahadur Singh.; Arvind Kumar Srivastava and Ram Pratap.
Chalcone based aryloxy propanolamines as potential antihyperglycemic agents,
Bioorganic & Medicinal chemistry Letters, 2007; 17: 799-802.
20.Rajendra Prasad Y.; P. Praveen Kumar.; P. Ravi Kumar.; A. Srinivasa Rao. Synthesis and
Antimicrobial Activity of Some New Chalcones of 2 – Acetyl pyridine. European
Journal of Chemistry, 2008; 5: 144–148.
21.Ruby John Anto.; K. Sukumaran.; Girija Kuttan.; M.N.A. Rao.; V. Subbaraju.;
Ramadasan Kuttan. Anticancer and antioxidant activity of Synthetic chalcones and
related compounds. Cancer Letters, 1995; 97: 33- 37.
22.Shah alam khan.; Bahar ahmed.; and Tanveer alam. Synthesis and antihepatotoxic activity
of some new chalcones containing 1,4-dioxane ring system. Pak. J. Pharma. Sci., 2006;
9(4): 290-294.
23.Simon Feldbaek Nielsen.; Thomas Boesen.; Mogens Larsen.; Kristian Schonning and
Hasse Kromann, Antibacterial chalcones-bioisosteric replacement of the 41-hydroxy
group, Bioorganic and Medicinal chemistry, 2004; 12: 3047-3054.
24.Sivakumar P.M.; S. Prabu Seenivasan.; Vanaja Kumar.; and Mukesh Doble. Synthesis,
antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives,
Bioorganic and Medicinal chemistry Letters, 2007; 17: 1695-1700.
25.Suryawanshi S.N.; Naveen Chandra.; Pawan Kumar.; Jyoti Porwal, Suman Gupta.
Chemotherapy of leishmaniasis part-VIII: Synthesis and bioevaluation of novel
chalcones. European Journal Medicinal Chemistry, 2008; 43: 2473–2478.
27.Xiaoling Liu and Mei-Lin Go. Antiproliferative activity of chalcones with basic
functionalities. Bioorganic and Medicinal chemistry, 2007; 15: 7021-7034.
28.Yi Xia.; Zheng – Yu Yang.; Peng Xia.; Kenneth F. Bastow.; Yuka Nakanishi and
Kuo-Hsiung Lee, Antitumor Agents, Part 202 Novel 21- Amino chalcones: Design, Synthesis
and Biological Evaluation. Bioorganic and Medicinal Chemistry Letters, 2000; 10:
699-701.
29.Ying Lan Jin.; Xing Yun Jin.; Feng Jin.; Dong Hwan Sohn.; and Hhak Sung Kim.
Structure Activity Relationship Studies of Anti-inflammatory TMMC Derivatives: 4-
Dimethylamino Group on the B Ring Responsible for Lowering the potency. Arch Pharm
Res., 2008; 31(9): 1145-1152.
30.Cheeseman K. H. and Slater T. F “An introduction to free radical biochemistry”. Br. Med.
Bull., 1993; 49: 479-487.
31.Gupta V.K et al., “Oxygen derived free radicals in clinical context” (review). Ind J. clini
Bio-chem, 1992; 7: 3-10.
32.Halliwell “Free radicals and antioxidants: a personal view”. Nutr. Rev., 1994; 52: